Kevin T Conroy is President and CEO of EXACT SCIENCES CORP. Currently has a direct ownership of 1.15 Million shares of EXAS, which is worth approximately $50 Million. The most recent transaction as insider was on May 01, 2023, when has been sold 709 shares (Common Stock) at a price of $30.02 per share, resulting in proceeds of $21,284. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M
7.46% 3M change
11.17% 12M change
Total Value Held $50 Million

Kevin T Conroy Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2023
BUY
Grant, award, or other acquisition
$21,284 $30.02 p/Share
709 Added 0.06%
1,208,015 Common Stock
Feb 28 2023
SELL
Open market or private sale
$636,625 $61.12 p/Share
10,416 Reduced 0.86%
1,207,306 Common Stock
Feb 27 2023
BUY
Exercise of conversion of derivative security
-
22,492 Added 1.81%
1,217,722 Common Stock
Feb 22 2023
SELL
Open market or private sale
$298,798 $62.72 p/Share
4,764 Reduced 0.4%
1,195,230 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
10,374 Added 0.86%
1,199,994 Common Stock
Feb 15 2023
SELL
Open market or private sale
$958,729 $65.59 p/Share
14,617 Reduced 1.21%
1,189,620 Common Stock
Feb 14 2023
BUY
Exercise of conversion of derivative security
-
31,132 Added 2.52%
1,204,237 Common Stock
Feb 13 2023
SELL
Open market or private sale
$292,217 $64.55 p/Share
4,527 Reduced 0.38%
1,173,105 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
9,705 Added 0.82%
1,177,632 Common Stock
Jul 01 2022
SELL
Open market or private sale
$285 $40.75 p/Share
7 Reduced 0.0%
1,167,927 Common Stock
May 02 2022
BUY
Grant, award, or other acquisition
$15,550 $47.41 p/Share
328 Added 0.03%
1,167,934 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$5,659,998 $23.92 p/Share
236,622 Added 16.85%
1,167,606 Common Stock
Mar 01 2022
SELL
Open market or private sale
$1,096,590 $76.69 p/Share
14,299 Reduced 1.51%
930,984 Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
29,887 Added 3.06%
945,283 Common Stock
Feb 24 2022
SELL
Open market or private sale
$1,901,533 $70.1 p/Share
27,126 Reduced 2.88%
915,396 Common Stock
Feb 23 2022
SELL
Open market or private sale
$358,231 $69.05 p/Share
5,188 Reduced 0.58%
883,879 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
58,643 Added 5.86%
942,522 Common Stock
Feb 22 2022
BUY
Exercise of conversion of derivative security
-
10,373 Added 1.15%
889,067 Common Stock
Feb 15 2022
SELL
Open market or private sale
$1,146,236 $79.55 p/Share
14,409 Reduced 1.61%
878,694 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
$7,278,626 $32.74 p/Share
222,316 Added 19.93%
893,103 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
6,407 Added 0.95%
670,787 Common Stock
Nov 01 2021
SELL
Open market or private sale
$1,588,637 $93.88 p/Share
16,922 Reduced 2.48%
664,380 Common Stock
Oct 01 2021
SELL
Open market or private sale
$1,599,184 $93.64 p/Share
17,078 Reduced 2.45%
681,302 Common Stock
Sep 01 2021
SELL
Open market or private sale
$1,981,683 $104.42 p/Share
18,978 Reduced 2.65%
698,380 Common Stock
Aug 02 2021
SELL
Open market or private sale
$2,146,775 $107.5 p/Share
19,970 Reduced 2.71%
717,358 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
ADPT
Adaptive Biotechnologies Corp Healthcare
SLGC
SomaLogic, Inc. Healthcare
ALGN
ALIGN TECHNOLOGY INC Healthcare
KTC

Kevin T Conroy

President and CEO
Madison, WI

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS